protein
| ligand for ITGA4 (VLA4A) |
|
FOXO1 is an essential upstream regulator of the VCAM1 gene |
|
RARRES2 plays anti-inflammatory roles by preventing TNF-induced VCAM1 expression and monocytes adhesion in vascular endothelial cells |
|
PTK2 inhibition resulted in the loss of the GATA4 transcription factor required for TNF-induced VCAM1 production |
|
ICAM1 and VCAM1, as reflecting endothelial dysfunction biomarkers, play key roles at the early stage of inflammatory response to facilitate leukocytes adhesion and transmigration in vascular endothelial cells |
|
ITLN1 inhibition of TNF-induced expression of VCAM1 and ICAM1 is mediated by its down-regulation of ERK/NFKB signaling pathway |
|
NFKB1 activity regulates mesenchymal stem cell accumulation at tumors, by inducing VCAM1 and thereby its interaction with tumor vessel endothelial cells |
|
regulatory role of CEBPA on VCAM1 expression |
|
ATF2 is likely functionally required for VEGFA-stimulated endothelial VCAM1 gene expression |
|
PDE4A inhibition regulates VCAM1 through a novel RAPGEF3-dependent mechanism, which involves regulatory epigenetic components and reduces neointima formation following vascular injury |
|
APOM suppressed TNF-induced expression of ICAM1 and VCAM1 through inhibiting the activity of NFKB1 |
|
GAS6-FOXO1 signaling axis plays an important role in VCAM1 expression in the context of venous thromboembolism (VTE) |
|
mitochondrial TSPO can inhibit phorbol 12-myristate 13-acetate (PMA)-induced endothelial inflammation via suppression of VCAM1 and mitochondrial ROS production in endothelial cells |
|
IRF5 targeted the expression of vascular cell adhesion molecule 1 (VCAM1) at the transcriptional level by binding to its promoter |